Detalhe da pesquisa
1.
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
Dig Dis
; 40(6): 719-727, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915480
2.
[Impact of Covid 19 on endoscopy in Germany]. / Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland.
Z Gastroenterol
; 59(12): 1278-1287, 2021 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-34687033
3.
Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels.
J Clin Med
; 13(1)2023 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38202147
4.
Evaluation of the ESGE recommendations for COVID-19 pre-endoscopy risk-stratification in a high-volume center in Germany.
Endosc Int Open
; 9(10): E1556-E1560, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540550
5.
Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination.
Vaccines (Basel)
; 9(12)2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960185
6.
Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
United European Gastroenterol J
; 9(9): 1081-1090, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655180